24/7 Market News- Biodexa Successfully Appeals Nasdaq Delisting
DENVER, Colo., Oct 16, 2024 (247marketnews.com)- Biodexa Pharmaceuticals (NASDAQ: BDRX) stated that its request for an extension of time to demonstrate compliance with the $1.00 minimum bid price requirement for continued listing on Nasdaq Stock Market LLC was approved by a Nasdaq Hearings Panel.
To move forward, Biodexa Pharmaceuticals must remain in compliance with Nasdaq Listing Rule 5550(a)(2), or the “Minimum Bid Price Requirement”. The Panel’s decision is contingent on the Company maintaining a closing bid price of at least $1.00 per share for at least 20 consecutive trading days by October 31, 2024.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (BDRX)
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/14/25 08:00 AM
- MoBot alert highlights: NASDAQ: RELI, NASDAQ: PTLE, NASDAQ: BDRX, NASDAQ: LSE, NASDAQ: GURE (06/18/25 07:00 AM)
- 24/7 Market News Snapshot 22 May, 2025 – Biodexa Pharmaceuticals plc American Depositary Shs (NASDAQ:BDRX)
- Breaking News: MoBot’s Latest Update as of 05/22/25 09:00 AM
- Breaking News: MoBot’s Latest Update as of 05/22/25 08:00 AM